ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO105

Prognostic Evaluation of Pediatric IgA Nephropathy Using Histological Criteria Including Macrophage Accumulation

Session Information

Category: Glomerular

  • 1004 Clinical/Diagnostic Renal Pathology and Lab Medicine

Authors

  • Ikezumi, Yohei, Fujita Health University School of Medicine , Toyoake, Japan
  • Matsumoto, Yuji, Fujita Health University School of Medicine , Toyoake, Japan
  • Hasegawa, Hiroya, Niigata University Medical and Dental Hospital, Niigata-City, niigata, Japan
  • Yamada, Takeshi, Niigata University Medical and Dental Hospital, Niigata-City, niigata, Japan
  • Nikolic-Paterson, David J., Monash Medical Centre, Clayton, Victoria, Australia
Background

There is no histological classification to predict disease flare in children with IgA nephropathy (IgAN). As macrophage (MQ) accumulation correlates with histological injury, we investigated new histological criteria to predict disease flare in pediatric IgAN.

Methods

A total of 73 children with biopsy proven IgAN underwent 2 years of steroid treatment followed by a protocol biopsy and then steroid tapering. The non-flare group successfully discontinued steroid treatment (N=61, 20.1±9.2 years at biopsy); the flare group exhibited increased proteinuria during the taper or cessation of treatment (N=12, 11.6±2.3 years at biopsy, p<0.05). Histological findings were evaluated using Oxford classification. Macrophage number and phenotype was assessed by immunofluorescence.

Results

At first (diagnostic) biopsy, urine findings were comparable between the two groups, but the flare group had a higher serum IgA level (279±83 vs 214±87 mg/dL; P<0.05). Biopsies revealed no difference in mesangial proliferation (M), endocapillary proliferation (E), glomerulosclerosis (S), tubulointerstitial fibrosis (T), and crescent formation (C); however, the flare group had more total MQ (CD68+ cells) (p<0.05) and M1 MQ (CD68+CD86+ cells) (p<0.05). In addition, M1 MQ correlated with glomerular M, E, S, C lesions (all P<0.01). At second (protocol) biopsy, the flare group had more severe S (p<0.01) and T (p<0.05) lesions, and more glomerular and interstitial M2 MQ (CD68+CD163+ cells) (both p<0.01 vs non-flare group). In addition, M2 MQ correlated with S and T lesions (both p<0.001). ROC analyses revealed glomerular MQ number >2.2 cells at first biopsy could predict disease flare by sensitivity of 83%.

Conclusion

MQ accumulation is a potential marker to predict disease flare in pediatric IgAN. The number of glomerular M1 MQ in active lesions at the first biopsy was related to flare occurrence, while glomerular and interstitial accumulation of M2 MQ in chronic lesions may predict disease flare in pediatric IgAN.

Funding

  • Government Support - Non-U.S.